Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial CarcinomaAndrea B. Apolo, Jonathan E. Rosenberg, Daniel M. Geynisman et al.|New England Journal of Medicine|2024Cited by 145
Proteogenomic analysis of the CALGB 40601 (Alliance) HER2+ breast cancer neoadjuvant trial reveals resistance biomarkersEric J. Jaehnig, Meenakshi Anurag, Aranzazu Fernandez-Martinez et al.|Cell Reports Medicine|2025Cited by 3
Abstract P5-02-36: Proteogenomic profiling of fresh frozen core biopsies from CALGB 40601Eric J. Jaehnig, Meenakshi Anurag, Aranzazu Fernández-Martínez et al.|Cancer Research|2023Cited by 0
Proteogenomic analysis of the CALGB 40601 (Alliance) HER2+ breast cancer neoadjuvant trial reveals resistance biomarkersLisa A. Carey, Haoquan Zhao, Chang In Moon et al.|UNC Libraries|2025Cited by 0